Doctor insights on:
No.: It seems to have proven efficacy. Fda approval is difficult to obtain, and is not necessary for access to this treatment. There will likely be more progress toward fda approval when there is more consistency in the timing, dosing and other treatments. But this treatment is readily available in several large pediatric centers, regardless of the lack of fda approval. ...Read moreSee 1 more doctor answer
Tumor evaluation: Mibg scintigraphy images tumours of neuroendocrine origin, particularly of neuro-ectodermal (pheochromocytomas, paragangliomas and neuroblastomas) , although other neuroendocrine tumours (carcinoids, medullary thyroid carcinoma.Can also be visualized. Radiation from i131 mibg is greater than imaging with i123 mibg. Resolution on latter images is considered better. ...Read moreSee 1 more doctor answer
7yrboy with stage 4 NB that did not respond to frontline tx. Currently receiving Mibg therapy . Prognosis ? Friend's son.
Ask your doctor: Disposition depends on clinical symptoms and results of tests. Mibg scan shows functioning tumors such as pheochromocytoma .Symptoms of pheo include headache, sweating, palpitations, elevated blood pressure, anxiety.Nodule usually needs characterization by mri. Adrenocortical carcinoma can produce hormones with virilization and feminization.Some asymptomatic nodules followed such as benign adenoma. ...Read more
What's the best test to detect a pheocromocytoma? Besides a mibg? Is it better to go with a pet scan or mri? I seem to have a sporadic pheo......
15yr old male,Adrenal pheochromocytoma with liver and lung metastasis.MIBG nuclide positive. is there’s any effective therapy besides chemo?
Pheochromocytoma: Adrenal pheochromocytoma is a rare cancer. Treatment options include surgical removal of primary tumor. Chemotherapy and radiation therapy is utilized with metastatic disease. Here is a reference from the NIH National Cancer Institute: https://www.cancer.gov/types/pheochromocytoma/patient/pheochromocytoma-treatment-pdq#link/_126_toc ...Read more